Ituri’s Ebola Window Is Already Narrow

The most dangerous number in Congo’s new Ebola outbreak is not 65. It is four.

As of Africa CDC’s May 15 update, health officials were reporting roughly 246 suspected Ebola cases and 65 deaths in Ituri province, but only four deaths had been reported among laboratory-confirmed cases, with suspected cases in Bunia still awaiting confirmation and the figures still being validated through lab testing, line-list reconciliation, contact identification and epidemiological investigation, according to Africa CDC¹. The World Health Organization, the United Nations health agency, separately reported 67 suspected community deaths linked to Ebola Bundibugyo in Mongbwalu and Rwampara health zones and warned about uncertainty over the scale of transmission in affected communities, according to WHO Africa².

That gap between suspected illness and confirmed disease is the outbreak’s central problem. Ebola disease is rare, severe and often fatal; it spreads through direct contact with the blood or other body fluids of someone who is sick or has died, or through contaminated objects and surfaces, according to the WHO fact sheet on Ebola disease³. But the early symptoms can look like malaria, typhoid, meningitis or other infections, which means a suspected Ebola case is not the same as a confirmed one, according to the same WHO guidance³. Until labs sort the real cases from the look-alikes, responders cannot reliably isolate patients, list contacts, secure burials or know whether the case fatality rate, the share of reported cases who die, is telling them anything real.

My view is blunt: this outbreak can still be stopped, but it is more likely to outrun purely local containment than to remain neatly boxed inside two Ituri health zones. That is not panic. Ebola is not airborne measles, and people are not infectious before symptoms, according to WHO³. The reason I am pessimistic is more practical. The tools that stop Ebola work only when they are fast, trusted and physically able to reach people. In Ituri, all three conditions are in doubt.

The first weak point is surveillance. Contact tracing means finding everyone who may have been exposed to a confirmed case and monitoring them through the incubation period, which for Ebola can run from two to 21 days, according to WHO³. If a person becomes sick, the response has to move quickly: isolate, test, treat, trace again. Africa CDC’s phrase “gaps in contact listing” should make readers sit up, because an incomplete contact list is not paperwork failure. It is an epidemiological blind spot, according to Africa CDC’s May 15 statement¹.

The numbers also should be read with care. If one simply divides 65 deaths by 246 suspected cases, the crude fatality figure is about 26 percent. But that number is almost certainly unstable because the numerator and denominator are both provisional: some suspected cases may not be Ebola, some community deaths may not yet be confirmed, and some living cases may be too early in their illness to know the outcome. WHO says Ebola’s average case fatality rate is around 50 percent, with past outbreaks ranging from 25 percent to 90 percent, according to its Ebola disease fact sheet³. In other words, the current count is less a scoreboard than a fogged windshield.

The second weak point is the strain. WHO says Congo’s national reference laboratory detected Ebola Bundibugyo in 13 of 20 samples from suspected cases linked to the Ituri cluster, according to WHO Africa². Bundibugyo is one of the Ebola-causing viruses known to produce large outbreaks; it was first identified in western Uganda in 2007, when 131 cases and 42 deaths were reported, according to WHO Africa². That matters because the most familiar Ebola response story in Congo has often meant Zaire ebolavirus, not Bundibugyo.

The distinction is not academic. WHO says licensed vaccines and therapeutics exist for Ebola virus disease caused by Ebola virus, meaning Zaire ebolavirus, but there is no approved vaccine or treatment for other Ebola diseases such as Sudan virus disease or Bundibugyo virus disease, though candidates are in development, according to the WHO fact sheet³. The U.S. Centers for Disease Control and Prevention says ERVEBO, the Merck vaccine approved by the Food and Drug Administration, prevents disease caused by Zaire ebolavirus and does not protect against other orthoebolavirus species, according to CDC vaccine information⁴.

That does not make Bundibugyo unstoppable. It does mean responders cannot casually import the mental model of the Zaire outbreaks, where ring vaccination became a powerful tool. Ring vaccination means vaccinating the contacts of a confirmed case, the contacts of those contacts, and frontline workers around an exposure chain. For Bundibugyo, the “ring” still matters as a tracing and monitoring structure, but the vaccine advantage is not the same unless a suitable investigational product can be deployed under an emergency protocol.

The third weak point is geography. Ituri is a northeastern province of the Democratic Republic of the Congo near Uganda and South Sudan. The affected areas are not hermetically sealed villages. Africa CDC flagged the urban context of Bunia and Rwampara, intense population movement, mining-related mobility in Mongwalu, proximity to Uganda and South Sudan, and cross-border risk, according to its regional coordination statement¹. WHO also said the outbreak area presents operational challenges including urban movement tied to mining, insecurity and frequent cross-border movement, according to WHO Africa².

The border risk is no longer theoretical. Uganda’s Ministry of Health reported a confirmed Ebola Bundibugyo case in a 59-year-old Congolese man who was admitted to Kibuli Muslim Hospital on May 11 and died on May 14; Uganda classified the case as imported from Congo and said no local case had yet been confirmed, according to Africa CDC¹. That last clause is important. It means regional spread has not yet become documented sustained transmission. But it also proves an infected person could get from the Ituri-linked risk zone to Kampala before the response had fully wrapped itself around the chain.

The fourth weak point is security and trust. Ebola response is intimate work. Someone has to ask families who touched whom, persuade sick people to isolate, collect samples, enter health facilities, supervise burials and explain why normal rituals must change. That work collapses when communities suspect outsiders, when armed groups control roads, or when health workers become targets.

This is where Congo’s experience cuts both ways. The 2018-2020 eastern Congo outbreak in North Kivu, Ituri and South Kivu was eventually ended, and WHO credits surveillance, contact tracing, laboratory services, infection prevention, clinical management, community engagement and safe burials, according to WHO’s June 2020 outbreak report⁵. But that outbreak was also Congo’s longest and the world’s second-largest after West Africa’s 2014-2016 catastrophe: 3,470 cases, 2,287 deaths, more than 250,000 registered contacts and more than 220,000 samples tested, according to WHO⁵. WHO specifically identified distrust, reluctance to enter Ebola treatment facilities, armed-group insecurity and attacks on health workers as factors that made containment hard, according to the same report⁵.

That history should discipline the optimistic case. Yes, Congo has institutional muscle. WHO said the country’s 2025 Kasai outbreak ended on December 1, 2025, after two incubation periods with no new case, with 64 cases, 45 deaths and 572 contacts followed, according to WHO’s Kasai outbreak report⁶. WHO also says it is airlifting five metric tonnes of supplies to Bunia and mobilizing experts in epidemiology, infection prevention, laboratory diagnostics, clinical care, logistics, risk communication and community engagement for the current Ituri response, according to WHO Africa². Africa CDC says it has activated a regional incident management structure, approved a 72-hour action plan for Congo and Uganda with South Sudan preparedness, and convened health authorities and partners for cross-border surveillance, lab support, sequencing, safe burials, contact management and resource mobilization, according to Africa CDC¹.

But a plan is not a field result. In April, the UN Secretary-General’s noon briefing said violence in Ituri was worsening the humanitarian situation, with the Plaine Savo displacement site hosting more than 70,000 displaced people and humanitarian access highly constrained by insecurity, according to the UN briefing⁷. That is the environment into which contact tracers now must walk.

The strongest counterargument is that Ebola control does not depend on one magic tool. That is true. WHO’s control package includes supportive care, infection prevention, surveillance, contact tracing, lab services, safe burials, vaccination if relevant and social mobilization, according to WHO³. Because people do not transmit Ebola before symptoms, a fast system can still beat the virus to the next chain. If Uganda’s imported case produces no secondary cases, if sample turnaround shrinks, if community deaths are tested quickly, if local leaders help bring contacts into monitoring, this could still become a hard but contained outbreak.

I just do not think that is the likelier default from today’s evidence. The outbreak is already a surveillance race in a conflict zone, involving a strain without the approved Zaire vaccine-and-treatment backbone, in a mobile mining and border economy, with one infected traveler already reaching Uganda’s capital. The question is not whether Ebola can be contained. It can. The question is whether Ituri’s response can become fast and trusted before the virus uses uncertainty, fear and movement to create unlinked chains.

My threshold is concrete: by the end of two incubation periods, roughly 42 days from this week’s confirmation, I would want to see no new unlinked confirmed chains outside the initial Ituri health zones, no secondary Ugandan transmission, sample results returning within 48 hours, and at least 90 percent of listed contacts being monitored daily. If those indicators are missing by late June, this will no longer be a localized outbreak with regional risk. It will be a regional emergency trying to catch up.